2Derdeyn CP,Chimowitz MI,Lynn MJ,et al.Aggressive medical treatment with or without stenting in high risk patients with intracranial artery stenosis (SAMMPRIS):the final results of a randomised trial.Lancet,2014,383:333-341.
3Albers GW,Goldstein LB,Hess DC,et al.Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.Stroke,2011,42:2645-2650.
5Thomalla G,Cheng B,Ebinger M,et al.DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR):a multicentre observational study.Lancet Neurol,2011,10:978-986.
6Sztriha LK,Manawadu D,Jarosz J,et al.Safety and clinical outcome of thrombolysis in ischaemic stroke using a perfusion CT mismatch between 3 and 6 hours.PLoS One,2011,6:e25796.
7Piironen K,Tiainen M,Mustanoja S,et al.Mild hypothermia after intravenous thrombolysis in patients with acute stroke:a randomized controlled trial.Stroke,2014,45:486-491.
8Fonarow GC,Smith EE,Saver JL,et al.Improving door-to needle times in acute ischemic stroke:the design and rationale for the American Heart Association/American Stroke Association's Target:Stroke initiative.Stroke,2011,42:2983-2989.
9Ferrari J,Knoflach M,Seyfang L,et al.Differences in process management and in-hospital delays in Treatment with ivthrombolysis.PLoS One,2013,8:e75378.
10Demaerschalk BM.Seamless integrated stroke telemedicine systems of care:a potential solution for acute stroke care delivery delays and inefficiencies.Stroke,2011,42:1507-1508.
